L. J. De-oliveria-andrade, D. Oliveira, A. Melo, and R. C. , Association between hepatitis C and hepatocellular carcinoma, J Glob Infect Dis, vol.1, pp.33-40, 2009.

N. Goossens and Y. Hoshida, Hepatitis C virus-induced hepatocellular carcinoma, Clin Mol Hepatol, vol.21, pp.105-119, 2015.

F. Conti, F. Buonfiglioli, and A. Scuteri, Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals, J Hepatol, vol.65, pp.727-760, 2016.

H. B. El-serag, F. Kanwal, and P. Richardson, Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection, Hepatology, vol.64, pp.130-137, 2016.

, World Health Organization. Hepatitis C: fact sheet, 2016.

J. Grebely, J. D. Raffa, and C. Lai, Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents, J Viral Hepat, vol.18, pp.32-41, 2011.

K. B. Kielland, K. Skaug, E. J. Amundsen, and O. Dalgard, All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: A controlled study, Journal of Hepatology, vol.58, issue.1, pp.31-37, 2013.

F. Xu, X. Tong, and A. J. Leidner, Hospitalizations And Costs Associated With Hepatitis C And Advanced Liver Disease Continue To Increase, Health Affairs, vol.33, issue.10, pp.1728-1735, 2014.

D. A. Goodkin, B. Bieber, and M. Jadoul, Mortality, hospitalization, and quality of life among patients with hepatitis c infection on hemodialysis, Clin J Am Soc Nephrol, vol.12, pp.287-97, 2017.

S. Katrak, L. P. Park, C. Woods, A. Muir, C. Hicks et al., Patterns of Healthcare Utilization Among Veterans Infected With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) and Coinfected With HIV/HCV: Unique Burdens of Disease, Open Forum Infectious Diseases, vol.3, issue.3, p.173, 2016.

J. W. Galbraith, J. P. Donnelly, and R. A. Franco, National estimates of healthcare utilization by individuals with hepatitis C virus infection in the United States, Clin Infect Dis, vol.59, pp.755-64, 2014.

J. B. Joy, R. M. Mccloskey, and T. Nguyen, The spread of hepatitis C virus genotype 1a in North America: a retrospective phylogenetic study, Lancet Infect Dis, vol.16, pp.698-702, 2016.

S. A. Mcdonald, S. J. Hutchinson, and S. M. Bird, Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infection, Int J Drug Policy, vol.22, pp.63-72, 2011.

S. C. Gordon, P. J. Pockros, and N. A. Terrault, Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection, Hepatology, vol.56, pp.1651-60, 2012.

Z. M. Younossi, M. Otgonsuren, and L. Henry, Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States, J Viral Hepat, vol.22, pp.137-182, 2015.

N. K. Martin, P. Vickerman, and G. Dore, The HCV epidemics in key populations (including PWID, prisoners, and MSM): the use of DAAs as treatment for prevention, Curr Opin HIV AIDS, vol.10, pp.374-80, 2015.

R. Maan, M. Van-tilborg, and K. Deterding, Safety and effectiveness of direct-acting antiviral agents for treatment of patients with chronic hepatitis C virus infection and cirrhosis, Clin Gastroenterol Hepatol, vol.14, pp.1821-1851, 2016.

N. Ford, Z. Shubber, and G. Meintjes, Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis, Lancet HIV, vol.2, pp.438-444, 2015.

D. Moher, A. Liberati, and J. Tetzlaff, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, vol.339, p.2535, 2009.

D. Moher, L. Shamseer, and M. Clarke, Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement, Syst Rev, vol.4, p.1, 2015.

S. H. Downs and N. Black, The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions, J Epidemiol Community Health, vol.52, pp.377-84, 1998.

B. D. Marshall and D. Werb, Health outcomes associated with methamphetamine use among young people: a systematic review, Addiction, vol.105, pp.991-1002, 2010.

, Preferred reporting items for systematic reviews and metaanalyses, PRISMA flow diagram, 2017.